drugset / Trial / NCT00012168

Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat

NCT00012168

Diagnostic

Summary

RATIONALE: New imaging procedures such as lymphoscintigraphy may improve the ability to detect the spread of mouth and throat cancer to lymph nodes in the neck. PURPOSE: Pilot study of lymphoscintigraphy followed by sentinel lymph node mapping and sentinel lymph node biopsy to detect lymph node metastases in the neck in patients who have mouth or throat cancer.

Timeline

Start
1999-05
Primary completion
2003-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject isosulfan blue Diagnostic / imaging agent Other

Indications